METTL Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of METTL Antibodies for investigating methyltransferases in cellular processes. METTL Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). METTL proteins are essential enzymes that catalyze RNA modifications, significantly impacting gene expression and cellular signaling pathways. RNA modifications by METTL proteins influence mRNA stability and translation regulation, making them central to normal cellular function. Alterations in METTL protein activity have been linked to various diseases, including cancer and neurodegenerative disorders. Research into METTL proteins continues to reveal potential therapeutic targets and biomarkers for disease detection and treatment. Understanding methylation mechanisms through METTL protein research advances our knowledge of fundamental biological processes. Investigating METTL proteins helps unlock new possibilities in disease treatment and prevention. Santa Cruz Biotechnology monoclonal antibodies for METTL proteins enable researchers worldwide to advance scientific understanding of cellular methylation processes and their impact on human health.